Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Targeted Agent to Mitigate Sepsis

April 20, 2016 3:14 pm | by Institute for Basic Science | News | Comments

Sepsis is caused by the immune system severely overreacting to an infection and attacking itself.

TOPICS:

Breakthrough Cholesterol Drugs Fizzle Amid Price Pushback

April 20, 2016 3:04 pm | by Matthew Perrone, AP Health Writer | News | Comments

When a powerful pair of cholesterol-lowering drugs first hit the market last summer, initial excitement in the medical community quickly turned to panic.

TOPICS:

Cellular Trojan Horse Yields Potential Cancer Treatment

April 20, 2016 1:58 pm | by Brigham and Women's Hospital | News | Comments

Prostate cancer tumors are characterized by a mixed cell population, which makes targeting the different kinds of cells with one treatment very difficult.

TOPICS:
Advertisement

Toward a Resistance Proof Antiviral That Can Treat Many Diseases

April 20, 2016 1:53 pm | by American Chemical Society | News | Comments

Scientists and health officials are marshalling forces to fight Zika, the latest in a string of recent outbreaks.

TOPICS:

Stand Up To Cancer Supports Innovative Research Grants for 10 Early-Career Scientists

April 20, 2016 9:25 am | by American Association for Cancer Research | News | Comments

Stand Up To Cancer (SU2C) announced Monday that it is awarding 10 grants of $750,000 each to early-career scientists to support innovative, high-risk, high-reward projects in cancer research. The announcement was made at the 2016 Annual Meeting of the American Association for Cancer Research, SU2C’s Scientific Partner.

TOPICS:

Slight Increase in Norwegian Drug Consumption in 2015

April 20, 2016 9:10 am | by Norwegian Institute of Public Health | News | Comments

Drug sales measured in defined daily doses (DDD) increased by 2 percent from 2014 to 2015. Revenue growth was 8.6 percent. This is shown in "Drug Consumption in Norway 2011-2015," a report issued by the Norwegian Institute of Public Health.

TOPICS:

NICE Recommends PTC's Duchenne Muscular Dystrophy Drug

April 20, 2016 8:59 am | News | Comments

The drug has been called a ‘step change’ in the management of the disease which causes progressive muscle wasting and is usually fatal by age 30.

TOPICS:

Nanoparticle Acts like Trojan Horse to Halt Asthma

April 20, 2016 8:59 am | by Northwestern University | News | Comments

The technology can be applied to food allergies as well.

TOPICS:
Advertisement

AbbVie, University of Chicago Announce Cancer Research Collaboration

April 20, 2016 8:46 am | News | Comments

Both organizations will work together to advance research in several areas of oncology.

TOPICS:

Positive Phase 1 Data Announced for Ebola Vaccine Regimen

April 20, 2016 8:40 am | News | Comments

The Phase 1 study tested a vaccine regimen containing two components.

TOPICS:

Pandemic E. Coli Strain H30 Cloaks Its Stealth Strategies

April 20, 2016 8:36 am | by UW Medicine | News | Comments

The bacterium E. coli comes in many different varieties.

TOPICS:

Merck’s Keytruda Shows Promise for Merkel Cell Carcinoma

April 19, 2016 4:20 pm | by Stephanie Guzowski, Editor | News | Comments

The immunotherapy trend continues at this year’s American Association for Cancer Research (AACR) annual meeting in New Orleans.

TOPICS:

Drug Target in Rare, Lethal Glandular Cancer Discovered

April 19, 2016 3:21 pm | by Yale University | News | Comments

New data shows that ACC and similar cancers could be treated with already available drugs.

TOPICS:

Scientists Propose Treatment for Severe Lung Diseases

April 19, 2016 3:14 pm | by Cincinnati Children's Hospital Medical Center | News | Comments

Researchers are following up their current study with further development of the targeted small molecule they recently discovered.

TOPICS:

UnitedHealth Ups 2016 Outlook after Surprisingly Strong 1Q

April 19, 2016 2:44 pm | by Tom Murphy, AP Business Writer | News | Comments

UnitedHealth hiked its 2016 forecast after the nation's largest health insurer topped Wall Street's first-quarter earnings expectations.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading